Postherpetic Neuralgia Market is driven by rising herpes zoster...

agregó una foto Health

2025-04-29 11:00:36 -

Postherpetic Neuralgia Market is driven by rising herpes zoster prevalence

Postherpetic neuralgia (PHN) represents a chronic neuropathic pain condition that persists after the resolution of herpes zoster (shingles) lesions. PHN management typically involves antiviral agents, analgesics, topical therapies, anticonvulsants, and antidepressants, each offering distinct mechanisms to mitigate nerve damage–related pain. The advantages of these products include...

0 Commentarios 0 Acciones 731 Views 0 Vista previa